Login to Your Account

Consolidates ADHD Drug Rights

Shire Buying Vyvanse Partner New River For $64 Per Share

By Jennifer Boggs

Wednesday, February 21, 2007
Shire plc, which partnered with New River Pharmaceuticals Inc. two years on a drug for attention deficit hyperactivity disorder, agreed to acquire the smaller firm for $2.6 billion in cash. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription